About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Massachusetts | 382 Studies

Clinical Trials Pancreatic CancerMassachusetts

Pancreatic Cancer Clinical Trials in Massachusetts

Find 382 clinical trials for pancreatic cancer near Massachusetts. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 382 trials

CompletedMEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.The objective of this study is to evaluate the safety, tolerability, and antitumor activity of oleclumab (MEDI9447) in combination with or without durvalumab plus chemotherapy in…NCT03611556·La Jolla, California and 26 others CompletedABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic StudyA Phase I open label followed by a Phase II randomized, controlled study to assess the efficacy and safety of ABTL0812 in combination with FOLFIRINOX for first-line treatment of…NCT04431258·Los Angeles, California and 23 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingA Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing TumorsThis is an open-label, multi-center, multi-cohort, Phase 2 study to evaluate the efficacy and safety of trastuzumab deruxtecan (T-DXd) for the treatment of selected…NCT04482309·Duarte, California and 88 others

Active not recruitingPhase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with advanced solid tumors that have a…NCT03785249·Birmingham, Alabama and 221 others

CompletedPhase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsThe purpose of this study is to determine the maximum dose of LDE225 and BKM120 that can be safely given together to patients and/or the dose that will be used in future studies.NCT01576666·Los Angeles, California and 22 others

CompletedPhase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced MalignanciesThe purpose of this study of MCS110 with PDR001 was to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and antitumor activity of the…NCT02807844·Boston, Massachusetts and 19 others

Active not recruitingTesting the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid TumorsThis phase I trial identifies the best dose, possible benefits and/or side effects of gemcitabine in combination with elimusertib (BAY 1895344) in treating patients with…NCT04616534·Bethesda, Maryland and 2 others

TerminatedA Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)This study will determine the safety and tolerability and establish a preliminary recommended Phase 2 dose of V941(mRNA-5671/V941) as a monotherapy and in combination with…NCT03948763·Gilbert, Arizona and 25 others

RecruitingStereotactic Magnetic Resonance Guided Radiation TherapyThis is a master prospective Phase I-II trial evaluating feasibility and efficacy of stereotactic magnetic resonance (MR) guided adaptive radiation therapy (SMART) in patients…NCT04115254·Boston, Massachusetts and 1 other

RecruitingBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)This is a study to evaluate the efficacy and safety of belzutifan monotherapy in participants with advanced pheochromocytoma/paraganglioma (PPGL), pancreatic neuroendocrine tumor…NCT04924075·Los Angeles, California and 83 others

CompletedPharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsProspective, open-label, dose-ranging, uncontrolled phase I/II study of Lurbinectedin in combination with irinotecan.NCT02611024·Santa Monica, California and 22 others

RecruitingEvaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue InjuryThe goal of this study is to investigate the efficacy of \[68Ga\]CBP8 to detect collagen deposition in radiation induced tissue injury.NCT04485286·Boston, Massachusetts

Active not recruitingStudy of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic CancerThis study will assess the safety and efficacy of avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal…NCT05669482·San Francisco, California and 11 others

TerminatedTusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid TumorsPrimary Objective: * For Cohort A, Cohort B, and Cohort C Part 2: To assess the antitumor activity of tusamitamab ravtansine in metastatic breast cancer (mBC) and tusamitamab…NCT04659603·Orlando, Florida and 28 others

CompletedSafety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast CancerThe purpose of this study is to assess safety of nab-paclitaxel based chemotherapy regimens administered prior to and/or in combination with nivolumab in Pancreatic Cancer, Non…NCT02309177·Sacramento, California and 14 others

CompletedOlaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based ChemotherapyA Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Maintenance Olaparib Monotherapy in Patients with gBRCA Mutated Metastatic Pancreatic Cancer whose…NCT02184195·Gilbert, Arizona and 102 others

CompletedDose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer PatientsThis phase Ib study includes two phases: dose escalation phase and safety expansion phase.NCT01487785·Boston, Massachusetts and 4 others

TerminatedStudy of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic AdenocarcinomaThis research study is evaluating a study drug to treat pancreatic exocrine insufficiency (PEI) during the first year after the diagnosis of pancreatic cancer while the…NCT03469258·Boston, Massachusetts

RecruitingProspective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk IndividualsThe purpose of this research is to see if adding blood-based tests and symptom review to standard-of-care pancreatic cancer screening procedures can identify cancer early among…NCT06122896·Boston, Massachusetts and 1 other

TerminatedQUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic CancerThis was a Phase 1/2 multi-institution prospective open label study in which subjects with metastatic, locally advanced unresectable or recurrent pancreatic cancer who previously…NCT01834235·San Francisco, California and 11 others

PreviousPage 2 of 20Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia